Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease.
about
Interventions for fatigue in inflammatory bowel diseaseAssessing health-related quality of life in patients with inflammatory bowel disease, in Crete, GreeceOptimising monitoring in the management of Crohn's disease: a physician's perspectiveVedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn diseaseRosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial.Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales.Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnairePreliminary evidence supporting a framework of psychological adjustment to inflammatory bowel diseaseThe role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure.Assessing patient reported outcome measures: A practical guide for gastroenterologists.Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitisThe impact of biologics on health-related quality of life in patients with inflammatory bowel disease.Optimizing management of Crohn's disease within a project management framework: results of a pilot study.Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trialQuality of life of patients with ulcerative colitis: past, present, and future.Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.Hyperactivated B cells in human inflammatory bowel disease.Strategies to improve quality of life in adolescents with inflammatory bowel disease.Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialHealth-related quality of life in patients with inflammatory bowel disease: a single-center experience.Future directions in inflammatory bowel disease management.Systematic review of health-related quality of life measures for inflammatory bowel disease.Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis.Clinical epidemiology of inflammatory bowel disease in Lebanon.Obesity Does Not Impact Perioperative or Postoperative Outcomes in Patients with Inflammatory Bowel Disease.Development of a short questionnaire to assess the quality of life in Crohn's disease and ulcerative colitis.Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales.B cells secrete eotaxin-1 in human inflammatory bowel disease.The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis.Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life.New tools and approaches for improved management of inflammatory bowel diseases.Factor structures of the Swedish Version of the RFIPC: Investigating the Validity of Measurements of IBD Patients’ Worries and Concerns.Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease.Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ).Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease.
P2860
Q24187375-9781F835-2B81-4693-A9A8-6A8F9F8CDEFEQ24802163-A3F773AF-C9F1-4E63-925C-D8EBC7A2988EQ27007083-EB564419-B361-4358-A6B1-498BB68E0F45Q30300234-B8723EAB-7975-46B9-9BEC-10419B35A2ABQ30405495-50E27C50-2829-4512-BB30-317BDB1EF182Q30440147-F3695C04-0A8F-46B8-B3B4-0C914ABB048AQ30666994-FD12C9DE-0096-434F-BF7D-0E87248BE9B0Q33457440-7E9AD52A-4981-4AF2-A59A-0C24CF7467E1Q33462837-34A3625C-2D26-4F62-8D66-0CCC390B4451Q33834727-589A740C-F0C0-4A86-AA15-D4508C8C2F36Q34158761-B3C1920D-8634-46DC-905D-DF7A153EEC1BQ34420136-C8DFC067-B902-448C-81FE-57B194BC03A0Q34576882-9E3B68E9-622C-449D-9805-49AC21B537FFQ34743223-CF0D3782-2260-480A-8123-1131BD62DBFCQ35026298-6AB84965-82D8-49D9-B5D3-8637802002A3Q35036687-BDC2F64D-7FD3-4DB2-A2B4-A30204D4BDAEQ36428382-37E17A05-B681-4371-8298-0F5F2A2D88DBQ36615895-38AA97B1-2A3D-43AE-979D-4000E15D0AFBQ36987080-04BE48F2-3C16-4DC8-9DCA-53CA191971EFQ37225167-2B1FE7FC-AD1F-4073-B050-E6CE30B988DCQ37486515-82F50DD6-F2F7-4A1F-B4EA-01E8D25020BDQ37497046-ED07FD59-6AEC-41C9-A70C-6249DACAFCE8Q37561775-1DFE6028-50EA-4B9E-B1A6-07F13D264050Q37647443-3589AA90-41B5-4715-B3F2-D6F39E8ED0C9Q38205305-503DF802-93D8-4915-8210-1B60E64022A8Q38313606-40E69118-3B59-4CCE-BFE5-FF9B68F2D4F1Q38412914-B03EFE6F-CC03-41BD-BAAD-11E43E390767Q40254045-DDD24B4B-A710-4ABB-B288-0F6EDEF6AD45Q40860216-168EF1E9-638B-4E4E-8B6D-B2A4CE92B4FCQ41678393-954E0920-7E8B-4F87-BC15-54B1679CC822Q41728797-2C6C0956-F885-47A0-93FF-30CB6D19CB2DQ42270278-D9C032C2-432E-481E-B959-A974FBE00328Q43407703-C63A7736-BC5D-4354-A430-59E88532FA51Q43648699-36156CD1-2F83-40D6-8F4B-F77173EDB373Q44326145-C9520139-2B46-46EA-BFC6-D4C29036E173Q46511762-F8E5E554-FA04-42C5-A176-74278E325354Q47115254-AED0C2CE-F5B6-4F5E-B35C-851ED545467AQ47720829-8A3AFB2B-5724-4193-9A92-3D5F7E32BF89Q47742192-05D26F54-E872-49B7-BB0E-EF4FB65168DBQ48000041-3FBE048F-CCAE-496E-A90D-3348ED3D6C4E
P2860
Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development and subsequent ref ...... th inflammatory bowel disease.
@ast
Development and subsequent ref ...... th inflammatory bowel disease.
@en
type
label
Development and subsequent ref ...... th inflammatory bowel disease.
@ast
Development and subsequent ref ...... th inflammatory bowel disease.
@en
prefLabel
Development and subsequent ref ...... th inflammatory bowel disease.
@ast
Development and subsequent ref ...... th inflammatory bowel disease.
@en
P921
P1476
Development and subsequent ref ...... th inflammatory bowel disease.
@en
P2093
P356
10.1097/00005176-199904001-00003
P407
P577
1999-04-01T00:00:00Z